Cite
MLA Citation
Jonathan A Bernstein et al.. “Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials.” Lancet, vol. 8, no. 5, 2020, pp. 461–474. http://access.bl.uk/ark:/81055/vdc_100103819303.0x000008